Schroder Investment Management Group Purchases 70,748 Shares of Humana Inc. $HUM

Schroder Investment Management Group grew its position in shares of Humana Inc. (NYSE:HUM) by 578.9% during the third quarter, according to its most recent filing with the SEC. The firm owned 82,969 shares of the insurance provider’s stock after acquiring an additional 70,748 shares during the period. Schroder Investment Management Group owned about 0.07% of Humana worth $21,586,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in HUM. Massachusetts Financial Services Co. MA boosted its position in shares of Humana by 273.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,488,261 shares of the insurance provider’s stock valued at $907,541,000 after purchasing an additional 2,553,509 shares in the last quarter. Norges Bank bought a new position in Humana in the second quarter worth $397,079,000. Bank of New York Mellon Corp raised its holdings in Humana by 161.5% in the third quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock worth $446,911,000 after purchasing an additional 1,060,767 shares in the last quarter. Dodge & Cox lifted its position in Humana by 5.6% during the second quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider’s stock valued at $2,775,562,000 after buying an additional 597,705 shares during the period. Finally, Neuberger Berman Group LLC boosted its holdings in shares of Humana by 2,855.5% during the 3rd quarter. Neuberger Berman Group LLC now owns 530,775 shares of the insurance provider’s stock valued at $138,092,000 after buying an additional 512,816 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HUM. KeyCorp reaffirmed a “sector weight” rating on shares of Humana in a research report on Friday, December 12th. Robert W. Baird lowered their price target on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research report on Thursday, December 11th. Royal Bank Of Canada cut shares of Humana from an “outperform” rating to a “sector perform” rating and cut their price objective for the stock from $322.00 to $189.00 in a report on Thursday, February 12th. JPMorgan Chase & Co. decreased their target price on shares of Humana from $274.00 to $180.00 and set a “neutral” rating for the company in a research note on Friday, February 13th. Finally, Zacks Research upgraded shares of Humana from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Seven equities research analysts have rated the stock with a Buy rating, sixteen have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, Humana presently has a consensus rating of “Hold” and a consensus price target of $225.48.

Insider Buying and Selling at Humana

In other news, insider Sanjay K. Shetty purchased 810 shares of Humana stock in a transaction that occurred on Monday, February 23rd. The stock was bought at an average price of $185.21 per share, with a total value of $150,020.10. Following the completion of the transaction, the insider directly owned 11,657 shares of the company’s stock, valued at approximately $2,158,992.97. The trade was a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.37% of the stock is owned by company insiders.

Humana Price Performance

HUM opened at $163.80 on Friday. The firm has a market cap of $19.66 billion, a PE ratio of 16.68, a P/E/G ratio of 1.75 and a beta of 0.44. The stock has a 50-day moving average price of $214.88 and a 200-day moving average price of $249.14. Humana Inc. has a 1 year low of $163.60 and a 1 year high of $315.35. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.00 and a quick ratio of 2.00.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, beating the consensus estimate of ($4.01) by $0.05. The company had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. Humana’s revenue for the quarter was up 11.3% on a year-over-year basis. During the same period in the prior year, the firm posted ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.2%. Humana’s dividend payout ratio is presently 36.05%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.